These findings are broadly consistent with findings by Yamamoto et al. (73), which showed a correlation between longitudinal changes in DAT uptake and progression of parkinsonism and cognitive symptoms in DLB. This evidence concerns the gene SLC6A3 and Lewy body dementia.